"Adult" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
| Descriptor ID |
D000328
|
| MeSH Number(s) |
M01.060.116
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adult".
Below are MeSH descriptors whose meaning is more specific than "Adult".
This graph shows the total number of publications written about "Adult" by people in this website by year, and whether "Adult" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 18 | 18 |
| 1997 | 0 | 20 | 20 |
| 1998 | 0 | 23 | 23 |
| 1999 | 0 | 22 | 22 |
| 2000 | 0 | 22 | 22 |
| 2001 | 0 | 20 | 20 |
| 2002 | 0 | 18 | 18 |
| 2003 | 0 | 26 | 26 |
| 2004 | 0 | 29 | 29 |
| 2005 | 0 | 30 | 30 |
| 2006 | 0 | 30 | 30 |
| 2007 | 0 | 40 | 40 |
| 2008 | 0 | 31 | 31 |
| 2009 | 0 | 57 | 57 |
| 2010 | 0 | 68 | 68 |
| 2011 | 0 | 54 | 54 |
| 2012 | 0 | 49 | 49 |
| 2013 | 0 | 45 | 45 |
| 2014 | 0 | 52 | 52 |
| 2015 | 0 | 66 | 66 |
| 2016 | 0 | 66 | 66 |
| 2017 | 0 | 59 | 59 |
| 2018 | 0 | 46 | 46 |
| 2019 | 0 | 51 | 51 |
| 2020 | 0 | 59 | 59 |
| 2021 | 0 | 50 | 50 |
| 2022 | 0 | 25 | 25 |
| 2023 | 0 | 26 | 26 |
| 2024 | 0 | 49 | 49 |
| 2025 | 0 | 35 | 35 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adult" by people in Profiles.
-
Survival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort. J Natl Cancer Inst. 2025 Nov 01; 117(11):2298-2307.
-
Impact of Case Detection and COVID-19-Related Disruptions on Tuberculosis in Vietnam: A Modeling Analysis. J Infect Dis. 2025 Oct 15; 232(4):e682-e690.
-
Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 2025 Oct; 13(10):e1681-e1690.
-
Evaluating the Impact of an eConsult Platform on Specialty Care Access for Medicaid Patients. J Am Board Fam Med. 2025 Sep 15; 38(3):592-598.
-
Exploring the relationship between depressive symptoms, allostatic load, and income inequality in US adults aged 20 and older. Soc Sci Med. 2025 Nov; 384:118594.
-
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol. Gynecol Oncol. 2025 Oct; 201:184-194.
-
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial. Diabetes Care. 2025 Sep 01; 48(9):1512-1516.
-
30-day outcomes of robotic versus laparoscopic Heller myotomy. Surg Endosc. 2025 Nov; 39(11):7592-7597.
-
Effectiveness and safety of perampanel by concomitant antiseizure medications: Insights from the real-world PERMIT Extension study. Epilepsy Behav. 2025 Oct; 171:110651.
-
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2025 Nov; 84(11):1888-1899.